Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Genet Couns. 2020 Sep 16;30(2):394–405. doi: 10.1002/jgc4.1324

Table 1:

Sample characteristics by study site and intervention group (N=52).

Tampa, FL Ponce, PR Tampa v. Ponce: p
Variables Overall (n=28) Intervention (n=15) Control (n=13) Int v. Control: p Overall (n=24) Intervention (n=11) Control (n=13) Int v. Control: p
Age (M, SD) 54.9 (7.0) 53.4 (7.0) 56.6 (6.9) 0.23 53.5 (10.7) 52.8 (12.2) 54.0 (9.8) 0.80 0.57
Partnered (N, %) 20 (71) 12 (80) 8 (62) 0.28 13 (54) 5 (45) 8 (62) 0.43 0.20
Education (N, %) 0.63 0.86 0.53
 <High School/GED 3 (11) 2 (13) 1 (8) 4 (17) 2 (18) 2 (15)
 ≥High School/GED 25 (89) 13 (87) 12 (92) 20 (83) 9 (82) 11 (85)
Household Income (N, %) 0.78 1.00 0.17
 <$35,000/year 18 (64) 10 (67) 8 (62) 18 (75) 9 (82) 9 (69)
 ≥$35,000/year 10 (36) 5 (33) 5 (38) 4 (17) 2 (18) 2 (15)
Insured (N, %) 23 (82) 14 (93) 9 (69) 0.10 23 (96) 11 (100) 12 (92) 0.35 0.12
Birthplace (N, %) 1.00 0.27 <0.01*
 Colombia 11 (39) 6 (40) 5 (38) 0 (0) 0 (0) 0 (0)
 Cuba 9 (32) 5 (33) 4 (31) 0 (0) 0 (0) 0 (0)
 Puerto Rico 6 (21) 3 (20) 3 (23) 23 (96) 10 (91) 13 (100)
 Mainland US 0 (0) 0 (0) 0 (0) 1 (4) 1 (9) 0 (0)
 Other 2 (7) 1 (7) 1 (8) 0 (0) 0 (0) 0 (0)
Years Since Diagnosis (M, SD) 7.8 (4.7) 8.8 (4.7) 6.6 (4.5) 0.23 5.4 (4.1) 3.6 (2.2) 6.9 (4.8) 0.05* 0.06
Cancer Stage (N, %) 0.57 0.10 0.52
 Local (0-II) 14 (50) 9 (60) 5 (38) 13 (54) 5 (45) 8 (62)
 Regional (III) 6 (21) 3 (20) 3 (23) 3 (13) 0 (0) 3 (23)
 Distant (IV) 4 (14) 2 (13) 2 (15) 1 (4) 1 (9) 0 (0)
 Don’t Know 4 (14) 1 (7) 3 (23) 5 (21) 4 (36) 1 (8)
 Missing 0 (0) 0 (0) 0 (0) 2 (8) 1 (9) 1 (8)
Treatment (N, %)
 Surgery 26 (93) 14 (93) 12 (92) 0.29 23 (96) 10 (91) 13 (100) 0.27 0.93
 Chemotherapy 22 (79) 15 (100) 7 (54) <0.01* 19 (79) 9 (82) 10 (77) 0.77 0.96
 Radiation Therapy 15 (54) 9 (60) 6 (46) 0.46 15 (53) 7 (64) 8 (62) 0.92 0.52
 Hormonal Therapy 9 (32) 10 (67) 9 (69) 0.89 8 (33) 5 (45) 3 (23) 0.22 0.54
*

p<0.05